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Abstract
Background: Onset of allergic asthma has a strong association with childhood but only a few studies have
analyzed incidence of asthma from childhood to late adulthood in relation to allergy. The purpose of the study was
to assess age-specific incidence of allergic and non-allergic asthma.
Methods: Questionnaires were sent to 8000 randomly selected recipients aged 20–69 years in Finland in 2016. The
response rate was 52.3% (n = 4173). The questionnaire included questions on e.g. atopic status, asthma and age at
asthma diagnosis. Asthma was classified allergic if also a physician-diagnosed allergic rhinitis was reported.
Results: The prevalence of physician-diagnosed asthma and allergic rhinitis were 11.2 and 17.8%, respectively. Of
the 445 responders with physician-diagnosed asthma, 52% were classified as allergic and 48% as non-allergic. Median
ages at diagnosis of allergic and non-allergic asthma were 19 and 35 years, respectively. Among subjects with asthma
diagnosis at ages 0–9, 10–19, 20–29, 30–39, 40–49, 50–59 and 60–69 years, 70, 62, 58, 53, 38, 19 and 33%, respectively,
were allergic. For non-allergic asthma, the incidence rate was lowest in children and young adults (0.7/1000/year). It
increased after middle age and was highest in older age groups (2.4/1000/year in 50–59 years old).
Conclusions: The incidence of allergic asthma is highest in early childhood and steadily decreases with advancing age,
while the incidence of non-allergic asthma is low until it peaks in late adulthood. After approximately 40 years of age,
most of the new cases of asthma are non-allergic.
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Background
Rackemann was the first to introduce the concept of
extrinsic/allergic and intrinsic/non-allergic asthma in
1947 and thus described the first phenotypes of asthma
[1]. Over recent decades, cluster analyses have confirmed
that asthma is more of a heterogeneous disorder rather
than just a single disease. Several phenotypes have been
introduced in addition to the ones established 70 years
ago [2–6], but differentiating the phenotypes in clinical
practice can be challenging. One of the answers appears
to be the age of asthma onset and subsequently the
division into childhood/early-onset and adult/late-onset
asthma [6, 7].
Childhood asthma is commonly associated with allergy
[8, 9]. Large cohorts have shown allergic sensitization as
a risk factor for development [10, 11] and persistence of
asthma in childhood [12]. On the other hand, there is a
lack of comprehensive studies on the relevance of allergy
to adult asthma. Although allergic sensitization has been
reported as a risk factor for asthma in adults [13, 14]
and adult-onset asthma [15], adult asthma is more often
non-allergic than allergic [7, 16]. Also, the rates of aller-
gic sensitization in adult-onset asthma are mostly below
50% [15–17]. According to a recent Finnish cluster ana-
lysis, allergic asthma diagnosed in adulthood was often
associated with respiratory symptoms already during
childhood [5]. However, contradicting results do also
exist and a U.S.-based study reported only a slight
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difference in allergic sensitization in early- and late-
onset asthma (72 and 63% in subjects with asthma onset
before and after 40 years of age, respectively) [18].
It appears that there is a lack of knowledge on the al-
lergic and non-allergic phenotypes of adult-onset asthma
and the relation between allergy and asthma onset age.
Our aim was to study the association between asthma
onset age and allergy by assessing age at diagnosis and
age-specific incidence of asthma in adult asthmatics with
and without allergic rhinitis in a population-based postal
questionnaire study conducted in Finland.
Methods
Study design and population
The present study is part of the FinEsS (Finland-Estonia-
Sweden) study, which is a postal questionnaire study on
respiratory epidemiology conducted in collaboration in
these three Northern European countries. Similar postal
surveys were conducted in 1996, 2006 and 2016. The
present study sample is part of the latest survey con-
ducted in Finland in February 2016 and is formed from
a random sample of 8000 subjects aged 20–69 years
from the population in western Finland (Hospital Dis-
tricts of Vaasa and Seinäjoki). The study sample was ob-
tained from the Finnish Population Register and it was
matched to the age and gender distribution of the popu-
lation in the geographical area of our study. Finland is a
bilingual country and the registered native language of a
subject determined whether questionnaire in Finnish or
Swedish language was used. The questionnaire was sent
to a random sample of 7986 subjects after exclusion of
subjects with unknown address. Two reminders were
sent to those not responding. The sample size was 7942
subjects after further exclusion of subjects with non-
analyzable data as shown in Fig. 1. In total, 4173 subjects
responded yielding to a response rate of 52.3%. Of the
responders, 206 were excluded because of missing data
regarding smoking habits and thus, the actual sample
size was 3967 responders included in the study. The
study protocol was approved by the Ethical Committee
of Helsinki University Hospital (approval number
200/13/03/00/15).
Study area
The study area is mainly rural with two major towns
(Seinäjoki and Vaasa, about 62,000 and 68,000 inhabi-
tants, respectively). It has a subarctic climate and the
yearly average temperature is 4 °C (from −7 °C in the
winter to 17 °C in the summer) [19]. The most common
allergic sensitizations in Finland are against dogs, cats
and pollens whereas sensitization to house dust mites
and molds is less common [20].
Questionnaire and definitions
The FinEsS questionnaire was developed from the Ob-
structive Lung Disease in Northern Sweden (OLIN)
questionnaire, which is modified from the Swedish
translation of the British Medical Research Council
(BMRC) questionnaire [21]. The questionnaire includes
questions on respiratory diseases, symptoms, medication
and comorbidities, risk factors and occupational factors
considered relevant in respiratory epidemiology.
A physician-diagnosed asthma was defined by an an-
swer “yes” to the question “Have you been diagnosed by
a doctor as having asthma?”. Age at asthma diagnosis
was determined by an answer to the question” What age
were you when asthma was diagnosed?”. Allergic rhinitis
was defined by an answer “yes” to either of the questions
“Have you been diagnosed by a doctor as having allergic
rhinitis caused by pollens (caused by e.g. birch, grass,
mugwort)?” or “Have you been diagnosed by a doctor as
having other allergic rhinitis (caused by e.g. cat or dog,
but not pollen)?”. Allergic conjunctivitis was defined by
an answer “yes” to the question “Have you been diag-
nosed by a doctor as having symptoms of allergy in your
eyes?”. Age at diagnosis of allergy was not asked for. We
used the presence and absence of allergic rhinitis as an
indication of asthma being allergic or non-allergic, re-
spectively. A sensitivity analysis was made by using the
presence of either allergic rhinitis, allergic conjunctivitis
or both as an indication of allergic asthma. Current
smokers were considered those who reported smoking
currently or during the 12months preceding the survey.
Ex-smokers reported previous smoking but had quit
smoking at least 1 year prior to the survey. Never
smokers did not report current or previous smoking.
Statistical analysis
Reconstructing age-specific incidence of asthma from cross-
sectional data
Incidence of asthma in different age groups was esti-
mated based on cross-sectional data on current age of
the responders and age at diagnosis of asthma [22, 23].
Longitudinal data were retrospectively reconstructed
from the questionnaire data as if the 3967 subjects were
a cohort of newborns recruited between 69 and 20 years
ago. A “time-to-event” (age at diagnosis of asthma) was
recorded for each individual, and the population at risk
at each age was updated by subtracting both events (sub-
jects reporting asthma diagnosed at younger age) and
censorships (asthma-naïve responders younger than the
age for which population at risk was calculated) from
the total sample.
In brief, subjects were divided into 10-year age groups
based on their current age, and annual incidence of
asthma per 1000 person-years (new asthma diagnoses/
1000/year) was calculated in each age group by dividing
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the number of incident asthmas in each group by age-
group-specific population at risk, dividing the result by
10 and further multiplying with 1000. The 10-year age
group -specific population at risk was a mean value of
annually calculated respective 10-year risks. With re-
spect to age 0, population at risk was all responders. For
ages 1–20 years, subjects reporting asthma diagnosed at
younger age than the age for which the population at
risk was calculated were subtracted to form the 1-year
population at risk. The youngest responders were 20
years of age at the time of the study. After age 20, the re-
sponders who did not report physician-diagnosed
asthma (i.e. asthma-naïve responders) and who were
younger than the age for which the population at risk
was calculated, were also subtracted from all responders
to calculate populations at risk for ages 21–69 years.
Fig. 1 Study flow chart
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Subjects reporting physician-diagnosed asthma but not
the age at diagnosis were excluded from calculations.
Controlling for differences between older and younger age
groups
When calculating incidence based on cross-sectional
data, incidence rates at younger age represent means
from several different age cohorts while incidence rates
at older age represent those from older age cohorts only.
Since different age cohorts may also have different over-
all incidence of atopy, relative proportion of allergic and
non-allergic asthma may vary between different age co-
horts and thus, might affect our estimates of early-onset
and late-onset asthma. Therefore, we calculated separ-
ately in different age groups the proportion of allergic
asthma among subjects with asthma diagnosed before
the age of 40 years.
Statistical comparisons
Statistical analyses were performed using SPSS software
version 23 (IBM Corporation, Armonk, NY) and 95%
confidence intervals (CI) were calculated with EpiTools
[24] by using the Wilson method. Mann-Whitney U test
was used for continuous variables and Pearson chi-
square test for categorical variables in comparisons be-
tween two groups. A p-value <0.05 was considered sig-
nificant. Results are presented as percentages (95% CI)
or medians (Interquartile range [IQR]).
Results
Characteristics of responders
Of the 7986 invited subjects, 4173 (52.3%) responded
(Fig. 1). Basic characteristics of the responders are given
in Table 1. Their median age was 53 years and a slight
dominance of women was observed (52.2%). Among the
3967 responders included in the final analysis, 445 re-
ported having a physician-diagnosed asthma yielding
asthma prevalence of 11.2% (95% CI 10.3–12.2%). More
in detail, 192 of 1898 men (10.1%; 95% CI 8.8–11.6%)
and 253 of 2069 women (12.2%; 95% CI 10.9–13.7%) re-
ported having asthma (p = 0.04) and the median age at
asthma diagnosis was 21 (IQR 7–43) years in men and
29 (IQR 15–45) years in women (p = 0.03). Of the re-
sponders, 47.5% were either current or ex-smokers.
Physician-diagnosed allergic rhinitis was reported by
7.2% of the subjects due to pollens only, by 3.1% due to
other airborne allergens only and by 7.5% due to both of
these, constituting 17.8% overall prevalence of allergic
rhinitis (Table 1). Allergic conjunctivitis was reported by
11.7% of the subjects. The non-responder analysis of the
study is published elsewhere [23].
Characteristics of responders with asthma according to
presence of allergic rhinitis
Of the 445 responders with physician-diagnosed asthma, 230
(51.7%) had also allergic rhinitis (asthma considered as aller-
gic) while 215 (48.3%) did not have allergic rhinitis (asthma
considered as non-allergic) (Table 2). Non-allergic asthmatics
were slightly older (58 vs 44 years, p < 0.001) and had a
clearly older age at diagnosis of asthma (35 vs 19 years, p <
0.001) as compared to allergic asthmatics. In addition, sub-
jects with non-allergic asthma had also slightly higher BMI
(p= 0.046) and were more frequently ex-smokers compared
to allergic asthmatics (p= 0.034) (Table 2).
Age-specific incidence of allergic and non-allergic asthma
and their proportions
Figure 2 shows incidence of allergic and non-allergic
asthma in different age groups. A steady decline was ob-
served in the incidence of allergic asthma with advancing
age. The incidence of allergic asthma was highest in the
youngest age group of 0–9 years (1.8/1000/year) and
lowest in the age group of 50–59 years (0.6/1000/year).
On the contrary, the incidence of non-allergic asthma
was quite low and steady during childhood and early
adulthood (about 0.7/1000/year) but it increased mark-
edly after middle age and was highest (2.4/1000/year) in
the age group of 50–59 year olds. Overall, the age-
specific variation in incidence seemed to be higher for
non-allergic than allergic asthma.
Figure 3 shows proportions of allergic and non-allergic
asthma among new diagnoses of asthma in different age
groups. In the age groups 0–9, 10–19, 20–29, 30–39, 40–
49, 50–59 and 60–69 years, 70.4, 62.0, 58.3, 52.5, 37.7,
19.2 and 33.3% of the new asthma cases, respectively, were
classified as allergic. More than 60% of the subjects with
asthma diagnosed in childhood (< 18 years) reported hav-
ing allergic rhinitis and thus were considered to have
Table 1 Characteristics of responders
Number of subjects N 3967
Agea Years 53 (38–63)
Female N (%) 2069 (52.2)
BMIb kg/m2 26.7 (4.9)
Smoking status N (%)
Current 798 (20.1)
Ex 1086 (27.4)
Never 2083 (52.5)
Physician-diagnosed asthma N (%) 445 (11.2)
Allergic rhinitis N (%) 706 (17.8)
No allergic rhinitis 3261 (82.2)
Allergic rhinitis due to pollen only 286 (7.2)
Allergic rhinitis due to non-pollen only 122 (3.1)
Allergic rhinitis due to pollen and non-pollen 298 (7.5)
apresented as median (IQR)
bbased on responses of 3886 subjects and presented as mean (SD)
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allergic asthma. Therefore, allergic asthma was the domin-
ant phenotype as compared to non-allergic asthma until
late twenties while non-allergic asthma became the
dominant phenotype around the age of 40 and up to 80%
of new cases of asthma were non-allergic in the older ages.
Sensitivity analysis and controlling for possible cohort effect
To assess if the results depend on the definition of aller-
gic asthma, a sensitivity analysis was performed and the
results were quite similar when allergic conjunctivitis
was included in the definition of allergy. Accordingly,
among responders with asthma diagnosed at ages 0–9,
10–19, 20–29, 30–39, 40–49, 50–59 and 60–69 years,
72.4, 66.2, 63.3, 57.6, 47.8, 26.9 and 44.4% respectively,
had either allergic rhinitis or allergic conjunctivitis or
both (see Additional file 1: Figure S1). Incidence of
non-allergic asthma was lowest in the younger ages
(0.6/1000/year) and highest in the older age groups
(2.2/1000/year in 50–59 years old) (see Additional file 2:
Figure S2).
Table 2 Characteristics of responders reporting physician-diagnosed asthma classified as allergic or non-allergic
Responders with physician-diagnosed
asthma and allergic rhinitis
Responders with physician-diagnosed
asthma without allergic rhinitis
p-value
Total N (%) 230 (51.7) 215 (48.3)
Agea Years 44 (32–59) 58 (39–66) < 0.001
Female N (%) 137 (59.6) 116 (54.0) 0.25
BMIa kg/m2 25.7 (23.2–29.6) 27.4 (23.8–31.5) 0.046
Smoking status N (%) 0.034
Current 42 (18.3) 46 (21.4)
Ex 67 (29.1) 82 (38.1)
Never 121 (52.6) 87 (40.5)
Allergic rhinitis N (%)
Allergic rhinitis due to
pollen only
64 (27.8)
Allergic rhinitis due to
non-pollen only
35 (15.2)
Allergic rhinitis due to
pollen and non-pollen
131 (57.0)
Age at asthma diagnosisa Years 19 (7–33) 35 (18–50) < 0.001
apresented as median (IQR)
Fig. 2 Incidence of new asthma diagnoses/1000 person-years divided into allergic (subjects with allergic rhinitis) and non-allergic (subjects
without allergic rhinitis) cases in different age groups
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We found that in our sample prevalence of allergic
rhinitis was lower in older age groups compared to
younger age groups (prevalence of allergic rhinitis was
23.4, 27.2, 23.5, 15.6 and 10.5% in the age groups 20–29,
30–39, 40–49, 50–59 and 60–69 years, respectively, p =
0.036). To assess if the dominance of allergic cases
among subjects diagnosed with asthma before the age of
40 years is dependent on the age cohort analyzed, we
compared the proportions of allergic asthmatics among
subjects diagnosed with asthma before the age of 40
years between three groups according to their current
age: currently below 40 years of age, 40–60 years and
over 60 years. Proportion of allergic asthma among
asthma diagnosed before the age of 40 years was not sta-
tistically significantly different between the age groups
(64% in subjects <40 years of age, 64% in subjects 40–60
years and 54% in subjects ≥60 years, p = 0.247).
Discussion
We found that the incidence of allergic asthma was
highest in childhood and gradually decreased in older
age whereas the incidence of non-allergic asthma peaked
in late adulthood. Most subjects with childhood-onset
asthma were allergic while most subjects with asthma
onset after 40 years of age were non-allergic.
Childhood-onset asthma is commonly associated with
allergy [8, 9]. Our results supported this as close to 70%
of responders with asthma diagnosed before 20 years of
age had also allergic rhinitis in adulthood. It has been
commonly recognized that asthma has its origin in
childhood and the atopic early-onset asthma is the most
important and widely recognized phenotype [25, 26].
However, a recent U.S.-based study showed adult-onset
asthma as being the dominant phenotype among women in
middle age [27]. In Finland during 2012–2013, 70% of new
asthma diagnoses were made in adults indicating that
adult-onset asthma is a clinically relevant phenotype [28].
Nevertheless, studies on adult-onset asthma are still scarce.
In our study, the combined incidences of allergic and non-
allergic asthma were highest after middle age and this was
mainly driven by new cases of non-allergic asthma.
In the current study, the proportion of allergic asthma
among new cases decreased steadily with advancing age
at asthma diagnosis. There are some previous results
that are in line with our finding, but in those studies age
at asthma diagnosis was classified into two or three clas-
ses instead of looking at the prevalence of allergy on a
wide range of asthma onset age classes [7, 29]. Accord-
ing to a European multi-center population-based study,
atopy explained a minority (12–21%) of adult-onset
asthma [17]. A Swedish and a Dutch study both reported
prevalence rates of around 45% for atopy in adult-onset
asthma [15, 16]. Warm et al. divided Swedish asthmatics
into three age groups according to the age of asthma on-
set (≤ 6 years, 7–19 years and ≥ 20 years) and reported a
decrease in the frequency of allergic sensitization in
adulthood with increasing age of asthma onset (86,
56 and 26%, respectively) [29]. Our study results
were similar as proportion of allergic rhinitis among
new cases of asthma declined below 50% after the
age of 35 years. To our knowledge this is the first
study that shows the proportions of allergic and
Fig. 3 Relative proportions of allergic (subjects with allergic rhinitis) and non-allergic (subjects without allergic rhinitis) cases of new asthma
diagnoses in different age groups
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non-allergic asthma in consequent 10-year age
groups at ages 0–69 years at asthma diagnosis.
Several studies using cluster analysis have also re-
ported early-onset atopic asthma as a distinct phenotype
[3, 6, 30]. The heterogeneity of phenotypes appears to
increase with advancing age at asthma onset, resulting in
the recognition of new phenotypes and risk factors espe-
cially in adult-onset asthma [5, 16, 31]. In our study, the
responders with non-allergic asthma were more obese
than allergic asthmatics. A phenotype of older, obese
and less atopic women with frequent exacerbations and
symptoms but at most only a moderate reduction in
lung function has previously been reported [3, 5, 6].
Late-onset asthma is suggested to be more often non-
allergic, severe and having a lower lung function than
early-onset asthma [7, 32]. Accordingly, a cluster of se-
vere late-onset less atopic asthma with eosinophilic in-
flammation and male-dominance has been identified [3].
A Finnish study with a follow-up of 12 years reported
two adult-onset asthma phenotypes consisting predom-
inantly of males [5]. The first cluster had non-atopic
males with moderate smoking history who developed
persistent airflow limitation at follow-up but with the
lowest number of uncontrolled asthma. The other clus-
ter contained older men with a heavy-smoking history,
poor lung function and mostly uncontrolled asthma.
Late-onset asthma phenotypes with milder clinical pic-
ture has also been reported such as a mild, untreated
and less atopic adult-onset asthma [30] and a nonsmok-
ing female-predominant cluster with good lung function
and well-controlled/partially controlled asthma [5]. Gen-
erally thought, phenotypes that present more severe or
symptomatic disease are especially identified in late-
onset asthma [5, 6, 16, 33].
The reason for the decline in the incidence of allergic
asthma with increasing age at asthma diagnosis may be
related to at least two factors. Firstly, atopic allergy often
begins in childhood and early adulthood while non-
allergic asthma may be related to cumulative exposure
to irritating factors such as occupational exposures and
smoking and thereby becomes evident only later in life
span after sufficient exposure times. Indeed, the higher
proportion of ex-smokers among the non-allergic asth-
matics in our study would support this hypothesis. An-
other reason may be the cohort effect that may affect
incidence when estimated from cross-sectional data.
Those subjects who have lived long enough to be able to
have got late-onset asthma, were born earlier and repre-
sent different cohorts with lower overall prevalence of
allergic sensitization than in younger generations. More-
over, according to population-based studies, the preva-
lence of allergic sensitization in general decreases with
increasing age due to low incidence and higher remis-
sion [34]. Prevalence rates over 50% for allergic
sensitization are reported among young adults compared
to 26–39% in adults over 50 years of age [18, 20, 34]. A
database search survey from the U.S. (2005–2006)
showed a lower rate of allergic sensitization in asth-
matics ≥55 years old when compared to 20–40 years old
(65 and 75%, respectively) [18]. In the same survey, it
was shown that if the analysis of asthma onset age and
allergy is restricted to only subjects who were at least 55
years old, the difference in the frequencies of atopic
sensitization between asthmatics with onset before or
after 40 years of age was low (72% vs 63%, respectively),
but the numbers of subjects were quite small (12 and 31,
respectively) to make firm conclusions. A recent Swedish
study reported a continued increase in the prevalence of
allergic asthma in the last 20 years (from 5.0% in 1996 to
7.3% in 2016) [35], which may reflect the overall increase
in the prevalence of atopic sensitization in new genera-
tions. Accordingly, in our sample the prevalence of allergic
rhinitis was significantly lower in the oldest age cohort.
However, in all age cohorts of our sample, asthma diag-
nosed before the age of 40 years was more often allergic
than non-allergic, and the difference between age cohorts
was not statistically significant in this regard. In the future,
when the currently young generations with higher preva-
lence of atopy grow old, also late-onset asthma may have
higher proportions of allergic cases.
In the present study, a responder was defined to have al-
lergic asthma if he had both physician-diagnosed asthma
and physician-diagnosed allergic rhinitis, but we did not
have any objective tests on allergic sensitizations. According
to a Swedish study, 83% of persons aged 21–40 years with
an atopic tendency (production of IgE antibodies against
any allergen) had allergic rhinitis, concluding that allergic
rhinitis is a good marker for allergic sensitization and clin-
ical allergy [29]. In another study, both allergic sensitization
and allergic rhinitis were significantly associated with inci-
dence of asthma in adulthood in bivariate analyses, but
interestingly only allergic rhinitis was associated with
asthma incidence in multivariate analysis [15]. This indi-
cates that a clinical allergy is a better predictor of asthma
than atopic sensitization, and allergic rhinoconjunctivitis
doubles the risk for incident asthma among adults [36].
Furthermore, allergic conjunctivitis is often associated with
allergic rhinitis and the term rhinoconjunctivitis is used
[37]. This was also observed in the present study as the sen-
sitivity analysis for allergic and non-allergic asthma in asso-
ciation with the age at asthma diagnosis did not noticeably
change when allergic conjunctivitis was included into the
definition of allergy (see Additional files 1 and 2). We did
not take allergic skin diseases into account when defining
allergy as the definition of allergic dermatitis/eczema is
not as uniform as respiratory tract allergic diseases and
poses a higher risk for misdiagnosis of allergy [37].
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The present study was cross-sectional in nature and we
did not specifically inquire whether the responder had al-
lergic rhinitis or other allergy symptoms at the time of
asthma diagnosis. For this reason, responders with asthma
and allergic rhinitis diagnosed at some point of their life
might not have had allergic rhinitis at the time of their
asthma diagnosis. However, it has been reported that both
allergic and non-allergic rhinitis usually precede asthma
onset in children and adults [38, 39].
Study limitations also include that no objective
measurements of lung function to confirm asthma
diagnosis were obtained. In Finland, a person with
persistent asthma is entitled to special reimburse-
ments for expenses of asthma medication if he/she
has an objectively confirmed variable expiratory air-
flow limitation or bronchial hyperresponsiveness as
determined in international asthma diagnostic guide-
lines [40]. Therefore, most of the asthma diagnoses in
Finland are based on lung function measurements
and the reliability of the reported asthma diagnosis
used in our study is probably high. There is a risk for
recall bias as we requested a self-reported age at
asthma diagnosis, which in Australia was estimated as
most often inaccurate [41] while in Sweden it has
been estimated as most often accurate [42].
Conclusions
The incidence of allergic asthma is highest in early child-
hood and steadily decreases during adulthood, while the
incidence of non-allergic asthma is low until it peaks in
late adulthood. After 40 years of age most new cases of
asthma are non-allergic. This study supports the concept
that late-onset asthma is a separate entity and the mech-
anisms behind it differ from asthma beginning in child-
hood or in early adulthood.
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